Table 3.
Cox regression analysis of cardiac mortalitya
Baseline Variable | HR | 95% CI | P |
---|---|---|---|
Cumulative mean predialysis serum β 2M level during follow-up (per 10-mg/L increase) | 1.10 | 0.99 to 1.21 | 0.079 |
Age (per 10-yr increase) | 1.51 | 1.35 to 1.68 | <0.001 |
Gender (female) | 0.83 | 0.63 to 1.10 | 0.20 |
Race (black) | 0.61 | 0.46 to 0.80 | <0.001 |
Diabetes | 1.88 | 1.45 to 2.44 | <0.001 |
Years on dialysis (per 1-yr increase) | 1.04 | 1.01 to 1.07 | 0.011 |
Urea distribution volume (per 1-L increase)b | 1.01 | 0.98 to 1.03 | 0.43 |
ICED score (per 1-U increase)c | 1.29 | 1.12 to 1.50 | 0.001 |
Serum albumin (per 1-g/dl increase) | 0.49 | 0.35 to 0.70 | <0.001 |
Residual kidney urea clearance (per 1-ml/min increase)d | 0.83 | 0.61 to 1.12 | 0.23 |
High-flux dialysis | 1.17 | 0.80 to 1.71 | 0.42 |
Ultrafiltration volume/postdialysis weight (per 1-L/70-kg increase) | 1.19 | 1.07 to 1.33 | 0.001 |
Analysis stratified by clinical center; n = 1813. The HR for the cumulative mean predialysis serum β2M level remained 1.10 per 10-mg/L increase, after adjustment for baseline use of venous catheters and baseline hematocrit in addition to the covariates included the table. CI, confidence interval; HR, hazard ratio.
Urea distribution volume as determined by kinetic modeling.
Severity score computed with diabetes excluded (21).
Normalized to 35 L of urea distribution volume.